Literature DB >> 19527266

Temporal and spatial expression patterns for the tumor suppressor Maspin and its binding partner interferon regulatory factor 6 during breast development.

Caleb M Bailey1, Naira V Margaryan, Daniel E Abbott, Brian C Schutte, Baoli Yang, Zhila Khalkhali-Ellis, Mary J C Hendrix.   

Abstract

Interferon regulatory factor 6 (IRF6) is a non-canonical member of the interferon regulatory factor family of transcription factors. We recently identified IRF6 as a novel Maspin-interacting protein in mammary epithelial cells. Maspin is a tumor suppressor in the breast and has also been implicated in mammary gland morphogenesis. To explore a possible role for IRF6 in conjunction with Maspin during mammary gland growth and differentiation, we examined the expression of IRF6 and Maspin during post-utero mammary gland development using a combination of in vitro and in vivo approaches. The data revealed that the expression of IRF6 and Maspin is temporally and spatially regulated throughout mammary gland development, with maximal expression of both proteins occurring in fully differentiated, lactating lobuloalveolar cells. We further show that IRF6 adopts a lumenal localization pattern following complete epithelial cell polarization and present new evidence for the secretion of IRF6 into the milk. These results support the hypothesis that IRF6 and Maspin are important for mammary epithelial cell differentiation, and advance our understanding of the Maspin-IRF6 partnership during normal mammary gland development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527266      PMCID: PMC3175741          DOI: 10.1111/j.1440-169X.2009.01110.x

Source DB:  PubMed          Journal:  Dev Growth Differ        ISSN: 0012-1592            Impact factor:   2.053


  32 in total

Review 1.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

2.  Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes.

Authors:  B J Barnes; P A Moore; P M Pitha
Journal:  J Biol Chem       Date:  2001-04-12       Impact factor: 5.157

3.  Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10.

Authors:  L Tait; H D Soule; J Russo
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

4.  In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.

Authors:  Delphine Duguay; François Mercier; John Stagg; Daniel Martineau; Jonathan Bramson; Marc Servant; Rongtuan Lin; Jacques Galipeau; John Hiscott
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

5.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

6.  Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells.

Authors:  L Y Yu-Lee; J A Hrachovy; A M Stevens; L A Schwarz
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

7.  Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells.

Authors:  Valerie A Odero-Marah; Zhila Khalkhali-Ellis; Jirapat Chunthapong; Sumaira Amir; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

8.  Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.

Authors:  M H Barcellos-Hoff; J Aggeler; T G Ram; M J Bissell
Journal:  Development       Date:  1989-02       Impact factor: 6.868

9.  Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch.

Authors:  Rebecca J Richardson; Jill Dixon; Saimon Malhotra; Matthew J Hardman; Lynnette Knowles; Ray P Boot-Handford; Paul Shore; Alan Whitmarsh; Michael J Dixon
Journal:  Nat Genet       Date:  2006-10-15       Impact factor: 38.330

10.  Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression.

Authors:  Richard W E Clarkson; Matthew T Wayland; Jennifer Lee; Tom Freeman; Christine J Watson
Journal:  Breast Cancer Res       Date:  2003-12-18       Impact factor: 6.466

View more
  15 in total

1.  Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies.

Authors:  Alexi Surette; Byong Hoon Yoo; Tallal Younis; Kara Matheson; Tarek Rameh; Jaime Snowdon; Gillian Bethune; Kirill V Rosen
Journal:  Breast Cancer Res Treat       Date:  2021-03-16       Impact factor: 4.872

Review 2.  The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin.

Authors:  Margarida M Bernardo; Sijana H Dzinic; Maria J Matta; Ivory Dean; Lina Saker; Shijie Sheng
Journal:  J Cell Biochem       Date:  2017-03-21       Impact factor: 4.429

3.  Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.

Authors:  Debra J Warejcka; Malathi Narayan; Sally S Twining
Journal:  Exp Eye Res       Date:  2011-07-27       Impact factor: 3.467

4.  An Essential Role of Maspin in Embryogenesis and Tumor Suppression.

Authors:  Sijana H Dzinic; M Margarida Bernardo; Xiaohua Li; Rodrigo Fernandez-Valdivia; Ye-Shih Ho; Qing-Sheng Mi; Sudeshna Bandyopadhyay; Fulvio Lonardo; Semir Vranic; Daniel S M Oliveira; R Daniel Bonfil; Gregory Dyson; Kang Chen; Almasa Omerovic; Xiujie Sheng; Xiang Han; Dinghong Wu; Xinling Bi; Dzenana Cabaravdic; Una Jakupovic; Marian Wahba; Aaron Pang; Deanna Harajli; Wael A Sakr; Shijie Sheng
Journal:  Cancer Res       Date:  2016-12-06       Impact factor: 12.701

5.  Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.

Authors:  M Margarida Bernardo; Yonghong Meng; Jaron Lockett; Gregory Dyson; Alan Dombkowski; Alexander Kaplun; Xiaohua Li; Shuping Yin; Sijana Dzinic; Mary Olive; Ivory Dean; David Krass; Kamiar Moin; R Daniel Bonfil; Michael Cher; Wael Sakr; Shijie Sheng
Journal:  Genes Cancer       Date:  2011-11

6.  Generation and characterization of a conditional allele of Interferon Regulatory Factor 6.

Authors:  Arianna L Smith; Youssef A Kousa; Akira Kinoshita; Kate Fodor; Baoli Yang; Brian C Schutte
Journal:  Genesis       Date:  2017-06-22       Impact factor: 2.487

Review 7.  Toward an orofacial gene regulatory network.

Authors:  Youssef A Kousa; Brian C Schutte
Journal:  Dev Dyn       Date:  2015-09-17       Impact factor: 3.780

8.  Periderm prevents pathological epithelial adhesions during embryogenesis.

Authors:  Rebecca J Richardson; Nigel L Hammond; Pierre A Coulombe; Carola Saloranta; Heidi O Nousiainen; Riitta Salonen; Andrew Berry; Neil Hanley; Denis Headon; Riitta Karikoski; Michael J Dixon
Journal:  J Clin Invest       Date:  2014-08-18       Impact factor: 14.808

9.  IRF6 Is Involved in the Regulation of Cell Proliferation and Transformation in MCF10A Cells Downstream of Notch Signaling.

Authors:  Talip Zengin; Burcu Ekinci; Cansu Kucukkose; Ozden Yalcin-Ozuysal
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

10.  Cell-autonomous and non-cell-autonomous roles for IRF6 during development of the tongue.

Authors:  Steven Goudy; Peggi Angel; Britni Jacobs; Cynthia Hill; Veronica Mainini; Arianna L Smith; Youssef A Kousa; Richard Caprioli; Lawrence S Prince; Scott Baldwin; Brian C Schutte
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.